Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis

Lenalidomide and dexamethasone (Rd)-based triplets, in particular carfilzomib-Rd (KRd) and daratumumab-Rd (DaraRd), represent a standard of care in lenalidomide-sensitive multiple myeloma (MM) patients in first relapse. Meta-analysis of randomized clinical trials (RCT), suggested better outcome with...

全面介绍

书目详细资料
Autores principales: Mangiacavalli, Silvia, Cartia, Claudio Salvatore, Galli, Monica, Pezzatti, Sara, Belotti, Angelo, Fazio, Francesca, Mina, Roberto, Marcatti, Magda, Cafro, Anna, Zambello, Renato, Paris, Laura, Barilà, Gregorio, Olivares, Cecilia, Pompa, Alessandra, Mazza, Rita, Farina, Francesca, Soldarini, Martina, Benvenuti, Pietro, Pagani, Giuseppina, Palumbo, Michele, Masoni, Valeria, Ferretti, Virginia Valeria, Klersy, Catherine, Arcaini1, Luca, Petrucci, Maria Teresa
格式: Online 文件 Texto
语言:English
出版: Fondazione Ferrata Storti 2022
主题:
Article - Plasma Cell Disorders
在线阅读:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973473/
https://www.ncbi.nlm.nih.gov/pubmed/36200419
http://dx.doi.org/10.3324/haematol.2022.281342

因特网

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973473/
https://www.ncbi.nlm.nih.gov/pubmed/36200419
http://dx.doi.org/10.3324/haematol.2022.281342

相似书籍